CINECA IRIS Institutional Research Information System

AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.812
EU - Europa 2.361
AS - Asia 2.014
SA - Sud America 252
AF - Africa 74
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.751
IT - Italia 1.071
CN - Cina 853
SG - Singapore 685
IE - Irlanda 217
BR - Brasile 216
DE - Germania 182
SE - Svezia 177
AT - Austria 120
UA - Ucraina 114
FR - Francia 113
VN - Vietnam 106
FI - Finlandia 90
GB - Regno Unito 63
KR - Corea 60
HK - Hong Kong 59
IN - India 54
SN - Senegal 50
JP - Giappone 48
CA - Canada 47
NL - Olanda 46
ID - Indonesia 39
PL - Polonia 37
BE - Belgio 27
CZ - Repubblica Ceca 20
AU - Australia 16
TW - Taiwan 15
RO - Romania 13
TR - Turchia 13
UZ - Uzbekistan 13
CH - Svizzera 12
ES - Italia 12
IR - Iran 12
PK - Pakistan 11
BY - Bielorussia 10
CL - Cile 10
AR - Argentina 9
EG - Egitto 9
MX - Messico 9
PH - Filippine 9
RU - Federazione Russa 9
BD - Bangladesh 8
TH - Thailandia 6
ZA - Sudafrica 6
MO - Macao, regione amministrativa speciale della Cina 5
NO - Norvegia 5
CO - Colombia 4
LT - Lituania 4
PT - Portogallo 4
SA - Arabia Saudita 4
VE - Venezuela 4
EC - Ecuador 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PE - Perù 3
UY - Uruguay 3
GR - Grecia 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
ML - Mali 1
MT - Malta 1
OM - Oman 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.536
Salva come PNG Salva come JPEG
Città #
Chandler 456
Singapore 396
Ashburn 360
Beijing 328
Torino 298
Santa Clara 252
Fairfield 245
Dublin 213
Turin 141
Houston 135
Ann Arbor 117
Vienna 110
Wilmington 108
Nyköping 103
Cambridge 96
Woodbridge 95
Seattle 77
Dearborn 70
Columbus 69
Medford 64
Dallas 62
Princeton 62
Guangzhou 61
Redwood City 58
Dong Ket 56
Villeurbanne 56
Centro 52
Shanghai 46
Milan 41
New York 41
Novara 41
Fremont 39
Jacksonville 38
Jakarta 38
Pisa 38
Los Angeles 37
Munich 37
Boston 35
Hong Kong 32
Warsaw 30
Boardman 29
Hangzhou 28
Nuremberg 28
Nanjing 27
San Diego 25
Buffalo 22
Düsseldorf 22
Hefei 21
Seoul 21
São Paulo 20
Brussels 18
Turku 17
Redondo Beach 16
Scilla 16
Chennai 15
Helsinki 15
Lappeenranta 15
Ottawa 15
Norwalk 14
Jinan 13
Xian 13
Ho Chi Minh City 12
Phoenix 12
Rome 12
San Francisco 12
The Dalles 12
Tokyo 12
Washington 12
San Mateo 11
Taipei 11
Wuhan 11
Amsterdam 10
London 10
Tianjin 10
Toronto 10
Chengdu 9
Frankfurt am Main 9
Silver Spring 9
Falls Church 8
Lauterbourg 8
Marche 8
Philadelphia 8
Upper Marlboro 8
Ancona 7
Austin 7
Garessio 7
Geneve 7
Shenyang 7
Central District 6
Fuzhou 6
Genoa 6
Hamburg 6
Hanoi 6
Hebei 6
La Jolla 6
Paris 6
Suzhou 6
Zhengzhou 6
Asti 5
Birmingham 5
Totale 5.372
Salva come PNG Salva come JPEG
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 850
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 451
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 377
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 257
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 243
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 229
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 192
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 188
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 178
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 169
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 165
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 160
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 159
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. 156
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 151
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 150
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 145
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 143
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 143
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 141
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 137
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 135
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 132
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 131
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 130
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 128
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 124
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 122
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 113
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle. 111
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 109
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 109
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 108
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle. 107
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 107
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 102
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 102
HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism 101
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 100
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 100
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 99
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 98
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 97
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 97
CD38 in chronic lymphocytic leukemia: from bench to bedside? 96
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 94
The Extracellular NADome Modulates Immune Responses 94
NAMPT: A critical driver and therapeutic target for cancer 93
A novel role of the CX(3)CR1/CX(3)CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. 89
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 89
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 86
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 86
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 83
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 80
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. 79
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES. 75
Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network. 62
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. 58
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 58
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 51
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 47
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 46
Totale 8.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.639
article - articoli 0
book - libri 0
conference - conferenze 6.818
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021897 0 0 0 59 117 55 124 85 109 110 92 146
2021/20221.099 77 77 59 80 70 104 47 42 51 115 234 143
2022/20231.328 122 147 26 182 103 311 79 61 152 41 61 43
2023/2024701 73 110 50 32 72 88 30 62 9 44 61 70
2024/20251.760 33 95 94 182 367 151 80 81 213 118 141 205
2025/2026872 321 129 208 214 0 0 0 0 0 0 0 0
Totale 8.712